首页> 外文期刊>Implementation Science >Human subjects protection issues in QUERI implementation research: QUERI Series
【24h】

Human subjects protection issues in QUERI implementation research: QUERI Series

机译:QUERI实施研究中的人类主题保护问题:QUERI系列

获取原文
       

摘要

Background Human Subjects protections approaches, specifically those relating to research review board oversight, vary throughout the world. While all are designed to protect participants involved in research, the structure and specifics of these institutional review boards (IRBs) can and do differ. This variation affects all types of research, particularly implementation research. Methods In 2001, we began a series of inter-related studies on implementing evidence-based collaborative care for depression in Veterans Health Administration primary care. We have submitted more than 100 IRB applications, amendments, and renewals, and in doing so, we have interacted with 13 VA and University IRBs across the United States (U.S.). We present four overarching IRB-related themes encountered throughout the implementation of our projects, and within each theme, identify key challenges and suggest approaches that have proved useful. Where applicable, we showcase process aids developed to assist in resolving a particular IRB challenge. Results There are issues unique to implementation research, as this type of research may not fit within the traditional Human Subjects paradigm used to assess clinical trials. Risks in implementation research are generally related to breaches of confidentiality, rather than health risks associated with traditional clinical trials. The implementation-specific challenges discussed are: external validity considerations, Plan-Do-Study-Act cycles, risk-benefit issues, the multiple roles of researchers and subjects, and system-level unit of analysis. Discussion Specific aspects of implementation research interact with variations in knowledge, procedures, and regulatory interpretations across IRBs to affect the implementation and study of best methods to increase evidence-based practice. Through lack of unambiguous guidelines and local liability concerns, IRBs are often at risk of applying both variable and inappropriate or unnecessary standards to implementation research that are not consistent with the spirit of the Belmont Report (a summary of basic ethical principles identified by the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research), and which impede the conduct of evidence-based quality improvement research. While there are promising developments in the IRB community, it is incumbent upon implementation researchers to interact with IRBs in a manner that assists appropriate risk-benefit determinations and helps prevent the process from having a negative impact on efforts to reduce the lag in implementing best practices.
机译:背景技术受试者保护的方法,特别是与研究审查委员会监督相关的方法,在世界各地有所不同。尽管所有这些旨在保护参与研究的参与者,但这些机构审查委员会(IRB)的结构和细节可能而且确实有所不同。这种差异会影响所有类型的研究,尤其是实施研究。方法2001年,我们开始了一系列相互关联的研究,以在退伍军人卫生管理局的初级保健中实施基于证据的抑郁症协作治疗。我们已经提交了100多个IRB申请,修订和续签,并与美国(美国)的13个VA和大学IRB进行了互动。我们提出了在整个项目实施过程中遇到的与IRB相关的四个总体主题,并且在每个主题内确定了关键挑战并提出了已证明有用的方法。在适用的情况下,我们将展示为协助解决IRB特定挑战而开发的过程辅助工具。结果实施研究存在一些独特的问题,因为这种类型的研究可能不适合用于评估临床试验的传统“人类受试者”范式。实施研究中的风险通常与违反保密性有关,而不是与传统临床试验相关的健康风险。讨论的特定于实施的挑战包括:外部有效性考虑因素,计划-研究-行为循环,风险-收益问题,研究人员和受试者的多重角色以及系统级分析单位。讨论实施研究的特定方面与跨IRB的知识,程序和法规解释的变化相互作用,从而影响实施和研究最佳方法以增加循证实践。由于缺乏明确的指导方针和对地方责任的担忧,内部评级委员会经常面临对实施研究采用不符合贝尔蒙特报告精神的可变和不适当或不必要的标准的风险(国家委员会确定的基本道德原则摘要) (保护人类生物医学和行为研究的主题),并阻碍开展循证质量改进研究。尽管IRB社区有可喜的发展,但实施研究人员有责任与IRB进行互动,以协助做出适当的风险收益确定,并防止该过程对减少实施最佳实践的滞后性产生负面影响。 。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号